Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Paclitaxel 2Carboplatin 2trametinib 1tislelizumab 1pembrolizumab 1dabrafenib 1camrelizumab 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Cetuximab 1Capecitabine 1Adjuvants, Pharmaceutic 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Laryngeal Neoplasms × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡